Plunkett Research Online: Cellmid Ltd

CELLMID LTD (CELMF:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cellmid Ltd develops and sells diagnostic and therapeutic products for diseases such as cancer and chronic inflammatory conditions. The company's operating segment includes Diagnostics Cellmid/Lyramid Australia and Consumer Health which includes Advangen Australia; Advangen USA and Advangen Japan. I.....



Cellmid Ltd
Ticker: CELMF
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 6292216830
Fax: 61 292218535
Address: 55 Clarence Street
Suite 204, Level 2
Sydney, NSW 2000 Australia

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Biotechnology

Ranks not available
Contacts Description

Cellmid Ltd develops and sells diagnostic and therapeutic products for diseases such as cancer and chronic inflammatory conditions. The company's operating segment includes Diagnostics Cellmid/Lyramid Australia and Consumer Health which includes Advangen Australia; Advangen USA and Advangen Japan. I.....See More See More

Auditor: Grant Thornton Audit Pty Ltd
Legal Advisor:
$USD, In whole numbers,
except marked * or %
2019 2018 2017 2016 2015 2014
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: